Jun Liu, Xiaoyu Hu, Guanghao Yu, Qingrong Wang, Liwei Gu, Jianying Shen, Qinghe Zhao, Hao Sun, Shi Wang, Zhongyuan Guo, Yu Zhao, Hai Ma
Alpha-enolase (ENO1), a multifunctional protein with carcinogenic properties, has emerged as a promising cancer biomarker because of its differential expression in cancer and normal cells. On the basis of this characteristic, we designed a cell-targeting peptide that specifically targets ENO1 and connected it with the drug doxorubicin (DOX) by aldehyde-amine condensation. A surface plasmon resonance (SPR) assay showed that the affinity for ENO1 was stronger (KD = 2.5 µM) for the resulting cell-targeting drug, DOX-P, than for DOX...
April 17, 2024: Biochemical Pharmacology